These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30297038)

  • 1. Advanced imaging modalities to detect cardiotoxicity.
    Awadalla M; Hassan MZO; Alvi RM; Neilan TG
    Curr Probl Cancer; 2018 Jul; 42(4):386-396. PubMed ID: 30297038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
    López-Fernández T; Thavendiranathan P
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
    Garg V; Vorobiof G
    Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity due to chemotherapy: role of cardiac imaging.
    Poulin F; Thavendiranathan P
    Curr Cardiol Rep; 2015 Mar; 17(3):564. PubMed ID: 25648628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.
    Moonen M; Oury C; Lancellotti P
    Curr Oncol Rep; 2017 Aug; 19(10):63. PubMed ID: 28791609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
    O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction.
    Ong DS; Scherrer-Crosbie M; Coelho-Filho O; Francis SA; Neilan TG
    Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):487-97. PubMed ID: 24650314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying cancer patients at risk for cardiotoxicity.
    Salvatici M; Sandri MT
    Future Oncol; 2015; 11(14):2077-91. PubMed ID: 26198838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers.
    Akhter N; Murtagh G; Yancy C
    Future Oncol; 2015; 11(14):2093-103. PubMed ID: 26198839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.
    Jain D; Russell RR; Schwartz RG; Panjrath GS; Aronow W
    Curr Cardiol Rep; 2017 May; 19(5):36. PubMed ID: 28374177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
    Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
    Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Techniques.
    Di Lisi D; Manno G; Novo G
    Curr Probl Cardiol; 2021 Jun; 46(6):100818. PubMed ID: 33756178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Imaging Methods for Chemotherapy-related Cardiotoxicity Screening and Related Radiation Exposure: Current Practice and Trends.
    Kolla BC; Roy SS; Duval S; Weisdorf D; Valeti U; Blaes A
    Anticancer Res; 2017 May; 37(5):2445-2449. PubMed ID: 28476812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardio-oncology: the role of advanced echocardiography in cancer patients.
    Venneri L; Zoppellaro G; Khattar RS
    Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity from the cardiologist's perspective.
    Caro Codón J; Rosillo Rodríguez SO; López Fernández T
    Future Cardiol; 2015 Jul; 11(4):425-32. PubMed ID: 26234492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.
    Khouri MG; Klein MR; Velazquez EJ; Jones LW
    Future Cardiol; 2015 Jul; 11(4):471-84. PubMed ID: 26235924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab.
    Gulati G; Zhang KW; Scherrer-Crosbie M; Ky B
    Curr Heart Fail Rep; 2014 Dec; 11(4):366-73. PubMed ID: 25079445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing for Cardiotoxicity from Metal-on-Metal Hip Implants with Advanced Multimodality Imaging Techniques.
    Berber R; Abdel-Gadir A; Rosmini S; Captur G; Nordin S; Culotta V; Palla L; Kellman P; Lloyd GW; Skinner JA; Moon JC; Manisty C; Hart AJ
    J Bone Joint Surg Am; 2017 Nov; 99(21):1827-1835. PubMed ID: 29088037
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.